Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MaxCyte, Inc. - Common Stock
(NQ:
MXCT
)
1.300
+0.050 (+4.00%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about MaxCyte, Inc. - Common Stock
< Previous
1
2
3
4
Next >
These stocks have an unusual volume in today's session
↗
Today 13:00 EDT
Via
Chartmill
Top movers analysis in the middle of the day on 2026-10-14: top gainers and losers in today's session.
↗
October 14, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
October 14, 2026
Via
Chartmill
MaxCyte (MXCT) Q2 2026 Earnings Call Transcript
↗
August 19, 2026
Revenue declined 15% year-over-year, but net losses narrowed significantly.
Via
The Motley Fool
Topics
Earnings
MaxCyte (NASDAQ:MXCT) Q1 2026 Results Beat Estimates, Stock Rises on Buyback
↗
May 12, 2026
Via
Chartmill
MaxCyte Inc (NASDAQ:MXCT) Reports Q4 2025 Revenue Miss and Cautious 2026 Outlook
↗
March 24, 2026
Via
Chartmill
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
MaxCyte Q2 Earnings Call Highlights
↗
August 12, 2026
MaxCyte (NASDAQ:MXCT) reported second-quarter 2026 revenue of $7.3 million, down 15% from $8.5 million a year earlier, as lower license revenue, timing of instrument placements and prior-year...
Via
MarketBeat
Topics
Earnings
There are notable gap-ups and gap-downs in today's session.
↗
May 13, 2026
Via
Chartmill
MaxCyte Q1 Earnings Call Highlights
↗
May 12, 2026
MaxCyte (NASDAQ:MXCT) reported lower first-quarter revenue compared with the prior year, as management said discontinued SPL programs and inventory management by its largest customer weighed on core...
Via
MarketBeat
Topics
Earnings
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
↗
March 24, 2026
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
Insights into MaxCyte's Upcoming Earnings
↗
November 11, 2025
Via
Benzinga
This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
↗
August 11, 2025
Via
Benzinga
Thursday's session: top gainers and losers
↗
August 07, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
August 07, 2025
Via
Benzinga
A Look at MaxCyte's Upcoming Earnings Report
↗
May 06, 2025
Via
Benzinga
Which stocks are moving on Thursday?
↗
August 07, 2025
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Traders are paying attention to the gapping stocks in Thursday's session.
↗
August 07, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
MaxCyte (MXCT) Q2 Revenue Drops 18%
↗
August 06, 2025
Via
The Motley Fool
Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
March 12, 2025
Via
Benzinga
These stocks are moving in today's after hours session
↗
March 11, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Earnings Scheduled For March 11, 2025
↗
March 11, 2025
Via
Benzinga
MarketBeat Week in Review – 01/20 - 01/24
January 25, 2025
Stocks surged higher as investors reacted positively to dovish tariff news; next week will be highlighted by the Federal Reserve meeting and some tech earnings
Via
MarketBeat
Topics
Economy
Government
World Trade
MaxCyte: Building the Future of Cell and Gene Therapy Innovation
January 23, 2025
MaxCyte's proprietary Flow Electroporation technology enables companies like Vertex and CRISPR Therapeutics to get FDA approved for their gene-editing therapy.
Via
MarketBeat
MXCT Stock Earnings: MaxCyte Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
MXCT stock results show that MaxCyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 08, 2024
Via
Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 08, 2024
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
